Medpage Today on MSN8dOpinion
Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved?
As a pediatric obesity medicine specialist, I have witnessed first-hand the benefits of GLP-1 receptor agonists in the ...
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
STAT2d
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
BioSpace7d
Can CB1 Inhibitors Make a Comeback in Obesity?
After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...
Outsourcing-pharma3d
Antag Therapeutics gets FDA clearance to start clinical trials with new obesity drug
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
Benefits Pro10d
The debate over obesity treatment: Drugs vs. lifestyle changes
Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...
The Local5d
French healthcare system won’t pay for new anti-obesity drug
with their GP’s approval. The ANSM said in a press release that the use of this type of drug as a treatment for obesity is restricted and can only be prescribed as a treatment by specialists ...
Health plans at 1 in 5 large companies cover weight-loss drugs for employees
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...
Yahoo Finance6d
Biotech UCB Mimics Obesity Drug Stocks With Skin Disease Focus
The stock is the best performer in Europe’s Stoxx 600 Health Care Index after obesity-drug ... strong since it was approved in the US a year ago to treat psoriasis. The drug is also available ...